#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Heritable pulmonary arterial hypertension Antithrombin III deficiency Autoimmune hepatitis Fabry's disease Paroxysmal nocturnal haemoglobinuria Bronchopulmonary dysplasia Von Willebrand's disease B-cell small lymphocytic lymphoma Glomerulonephritis rapidly progressive Gastroenteropancreatic neuroendocrine tumour disease Gaucher's disease type I HER2 gene amplification Neuroendocrine tumour of the lung Selective polysaccharide antibody deficiency Haemophilia A with anti factor VIII More trials…

    Learn about Rare Diseases

    Leukoencephalopathy Vascular malformation – Trials in Disease Gaucher’s disease type III – Diagnostics Chordoma – Trials in Disease Ornithine transcarbamoylase deficiency – Diagnostics Mitochondrial myopathy – Diagnostics Amyotrophic lateral sclerosis – Basic Information Primary hyperoxaluria Mucous membrane pemphigoid – Basic Information Breast angiosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tasquinimod Propranolol Hydrochloride Dog Epithelium Extract Remifentanil Hydrochloride Pemetrexed Linezolid POTASSIUM CLAVULANATE Ioversol Sertindole Naporafenib Alisertib Sodium Vericiguat L-ALANINE Gskvx000000017033 Riboflavin Bp L-Tyrosine Ceftazidime Ng004 Atazanavir AMG 732 More therapies…

    Learn about Your Condition

    Cognitive disorder Mantle cell lymphoma stage III Herpes simplex reactivation Haemofiltration Peripheral ischaemia Milk allergy Ovarian cancer stage III Exudative retinopathy Dyspnoea Hyperplasia adrenal Pyoderma Hypertonic bladder Myositis Mantle cell lymphoma recurrent Myofascial pain syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Musculoskeletal Diseases

  • Study on the Effects of Satralizumab in Children and Adolescents with Duchenne Muscular Dystrophy

    Not recruiting

    2 1 1
    Denmark Italy Poland Spain

  • Study on the Effectiveness and Safety of DFL24412 and Ketoprofen Lysine in Patients with Chronic Low Back Pain

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Ketoprofen Lysine
    • Gabapentin
    • Paracetamol
    Italy Spain

  • Study on Treating Acute Gout Attacks with Prednisolone and Colchicine for Primary Care Patients

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Colchicine
    • Prednisolone
    Germany

  • Study Comparing MAB-22 and Denosumab for Treating Osteoporosis in Postmenopausal Women

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteoporosis
    Investigated Drugs:
    • Denosumab
    Bulgaria Czechia Poland

  • Study on the Effects of TransCon CNP in Children Aged 2-11 with Achondroplasia

    Not recruiting

    2 1
    Investigated Drugs:
    • C-Type Natriuretic Peptide Conjugated To A Multi-Arm Polyethylene Glycol Carrier Molecule Through A Cleavable Linker
    Denmark Ireland Spain

  • Long-term Safety Study of INZ-701 for Patients with ENPP1 and ABCC6 Deficiencies, Including Pseudoxanthoma Elasticum and Generalized Arterial Calcification of Infancy

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Recombinant Human Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 Fused To The Fc Fragment Of Igg1
    France Germany
Previous Page
1 … 46 47 48 49 50 … 67
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!